These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 760559)

  • 1. Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report.
    Rosenfeld AA
    Am J Psychiatry; 1979 Feb; 136(2):226-8. PubMed ID: 760559
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infantile psychosis secondary to methylphenidate].
    Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B
    Rev Neurol; 2011 Apr; 52(7):446-7. PubMed ID: 21425116
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of disulfiram-methylphenidate interaction: implications for treatment.
    Caci H; Baylé F
    Am J Psychiatry; 2007 Nov; 164(11):1759. PubMed ID: 17974945
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychosis induced by the interaction between disulfiram and methylphenidate may be dose dependent.
    Grau-López L; Roncero C; Navarro MC; Casas M
    Subst Abus; 2012; 33(2):186-8. PubMed ID: 22489591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychosis in a cocaine-dependent patient with ADHD during treatment with methylphenidate.
    Delavenne H; Duarte Garcia F; Lacoste J; Cortese S; Charles-Nicolas A; Ballon N
    Gen Hosp Psychiatry; 2013; 35(4):451.e7-9. PubMed ID: 22739113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder.
    Lakić A
    Vojnosanit Pregl; 2012 Feb; 69(2):201-4. PubMed ID: 22500377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression following pemoline withdrawal in a hyperactive child.
    Brown RT; Borden KA; Spunt AL; Medenis R
    Clin Pediatr (Phila); 1985 Mar; 24(3):174. PubMed ID: 3971647
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of withdrawal of Ritalin LA in the Western Cape.
    Donker Fv; Riordan G; Wilmshurst J
    S Afr Med J; 2008 Aug; 98(8):570. PubMed ID: 18928026
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of methylphenidate for attention deficit hyperactivity disorder.
    Kline CL
    CMAJ; 1990 Aug; 143(3):170-2. PubMed ID: 2073248
    [No Abstract]   [Full Text] [Related]  

  • 13. A drug to ease attention deficit-hyperactivity disorder.
    Smitherman CH
    MCN Am J Matern Child Nurs; 1990; 15(6):362-5. PubMed ID: 2124318
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of methylphenidate for attention deficit hyperactivity disorder. Mental Health Committee, Canadian Paediatric Society.
    CMAJ; 1990 Apr; 142(8):817-8. PubMed ID: 2322913
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Ghanizadeh A
    J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 18. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
    Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced psychosis after intake of a modified--release formulation of methylphenidate].
    Greiner C; Enss E; Haen E
    Psychiatr Prax; 2009 Mar; 36(2):89-91. PubMed ID: 18504693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity.
    Bloom AS; Russell LJ; Weisskopf B; Blackerby JL
    J Am Acad Child Adolesc Psychiatry; 1988 Jan; 27(1):88-9. PubMed ID: 3343212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.